Medpace Stock Nosedives On Mixed Quarterly Report, Sales Guidance Trim
Medpace (MEDP) stock crumbled Tuesday on a “shocking bookings miss” and after the clinical research organization slashed its 2024 sales guidance by $25 million at the midpoint. ↑ X NOW PLAYING How To Buy Stocks: Profit From Earnings Reports Using This Option Strategy During the three months ended June 30, Medpace booked $551 million in